: The Invisalign maker dominated the orthodontic market, reaching record annual sales. It was one of the year's top performers with a 131% return .
It ranked among the top 10 S&P 500 performers with an . Biotech and Healthcare Breakthroughs
Revenues were projected to triple, supporting its in 2017. best stocks to buy right now 2017
: Transformed into a biotech giant following breakthroughs in cystic fibrosis treatments.
: High-volatility winners included Madrigal Pharmaceuticals (+516%) and Sangamo Therapeutics (+438%) due to positive clinical trials and collaboration deals. Blue-Chip Staples and Value Plays : The Invisalign maker dominated the orthodontic market,
: Surged due to rising prices and high demand for memory chips (DRAM and NAND).
: Capitalized on the e-commerce boom and rising digital transaction volumes. Blue-Chip Staples and Value Plays : Surged due
Significant R&D payoffs led to massive gains for select pharmaceutical and health-tech companies.